These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22996365)

  • 21. Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.
    Abe Y; Muto M; Nieda M; Nakagawa Y; Nicol A; Kaneko T; Goto S; Yokokawa K; Suzuki K
    Exp Hematol; 2009 Aug; 37(8):956-68. PubMed ID: 19409955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired function of gamma-delta lymphocytes in melanoma patients.
    Petrini I; Pacini S; Galimberti S; Taddei MR; Romanini A; Petrini M
    Eur J Clin Invest; 2011 Nov; 41(11):1186-94. PubMed ID: 22775565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes.
    Lai D; Wang F; Chen Y; Wang C; Liu S; Lu B; Ge X; Guo L
    Cancer Immunol Immunother; 2012 Jul; 61(7):979-89. PubMed ID: 22120758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
    Devaud C; Bilhere E; Loizon S; Pitard V; Behr C; Moreau JF; Dechanet-Merville J; Capone M
    Cancer Res; 2009 May; 69(9):3971-8. PubMed ID: 19383918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of innate immunity by IL-18.
    Li W; Yamamoto H; Kubo S; Okamura H
    J Reprod Immunol; 2009 Dec; 83(1-2):101-5. PubMed ID: 19853308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
    D'Asaro M; La Mendola C; Di Liberto D; Orlando V; Todaro M; Spina M; Guggino G; Meraviglia S; Caccamo N; Messina A; Salerno A; Di Raimondo F; Vigneri P; Stassi G; Fourniè JJ; Dieli F
    J Immunol; 2010 Mar; 184(6):3260-8. PubMed ID: 20154204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z; Guo B; Lopez RD
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.
    Wang X; Mou W; Han W; Xi Y; Chen X; Zhang H; Qin H; Wang H; Ma X; Gui J
    Clin Immunol; 2019 Jun; 203():63-71. PubMed ID: 30999035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells.
    Muraro M; Mereuta OM; Carraro F; Madon E; Fagioli F
    Cell Immunol; 2007 Oct; 249(2):63-72. PubMed ID: 18163982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulated γδ T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer.
    Capietto AH; Martinet L; Fournié JJ
    J Immunol; 2011 Jul; 187(2):1031-8. PubMed ID: 21670311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.
    Nada MH; Wang H; Workalemahu G; Tanaka Y; Morita CT
    J Immunother Cancer; 2017; 5():9. PubMed ID: 28239463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
    Gaafar A; Aljurf MD; Al-Sulaiman A; Iqniebi A; Manogaran PS; Mohamed GE; Al-Sayed A; Alzahrani H; Alsharif F; Mohareb F; Ajarim D; Tabakhi A; Al-Hussein K
    Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
    Mattarollo SR; Kenna T; Nieda M; Nicol AJ
    Cancer Immunol Immunother; 2007 Aug; 56(8):1285-97. PubMed ID: 17265022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
    Guo BL; Liu Z; Aldrich WA; Lopez RD
    Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
    Iwasaki M; Tanaka Y; Kobayashi H; Murata-Hirai K; Miyabe H; Sugie T; Toi M; Minato N
    Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.
    Kunzmann V; Smetak M; Kimmel B; Weigang-Koehler K; Goebeler M; Birkmann J; Becker J; Schmidt-Wolf IG; Einsele H; Wilhelm M
    J Immunother; 2012; 35(2):205-13. PubMed ID: 22306909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
    Petrini I; Pacini S; Petrini M; Fazzi R; Trombi L; Galimberti S
    Eur J Clin Invest; 2009 Sep; 39(9):813-8. PubMed ID: 19522834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
    Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M
    J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.